Sagimet Biosciences Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Sagimet Biosciences Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2022 to Q3 2024.
  • Sagimet Biosciences Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$14.6M, a 130% decline year-over-year.
  • Sagimet Biosciences Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$37.5M, a 39.4% decline year-over-year.
  • Sagimet Biosciences Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$27.9M, a 8.6% increase from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$37.5M -$14.6M -$8.27M -130% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$29.3M -$8.12M -$1.33M -19.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-14
Q1 2024 -$27.9M -$6.63M -$42K -0.64% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-14
Q4 2023 -$27.9M -$8.15M -$956K -13.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 -$26.9M -$6.35M +$1.11M +14.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$28M -$6.79M +$317K +4.46% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-14
Q1 2023 -$28.4M -$6.59M +$2.15M +24.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-14
Q4 2022 -$30.5M -$7.2M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 -$7.47M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$7.1M Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$8.74M Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.